SYRS
Syros Pharmaceuticals, Inc. Common Stock
SYRS
SYRS
Delisted
SYRS was delisted on the 19th of March, 2025.
58 hedge funds and large institutions have $147M invested in Syros Pharmaceuticals, Inc. Common Stock in 2023 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 16 increasing their positions, 8 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
21% more funds holding
Funds holding: 48 → 58 (+10)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
58
Holding in Top 10
1
Calls
$684K
Puts
$9K
Top Buyers
| 1 | +$11.5M | |
| 2 | +$10.5M | |
| 3 | +$8.46M | |
| 4 |
AG
Artal Group
Luxembourg
|
+$8.02M |
| 5 |
SB
Samsara BioCapital
Palo Alto,
California
|
+$7.05M |
Top Sellers
| 1 | -$397K | |
| 2 | -$203K | |
| 3 | -$114K | |
| 4 |
SC
Shay Capital
New York
|
-$93.9K |
| 5 |
LPL Financial
San Diego,
California
|
-$67.4K |